chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient states she had hives all over her body, a headache, and suffered 2 asthma attacks. She received treatment at a clinic within 24-48 hours of immunization. Given steroid shot for shortness of breath. Symptoms started when she woke up 8/27/11, went to clinic 8/28/11.
Patient received vaccine on 12/9/10 and noticed pain and significant swelling in arm on 12/11/10 referred to MD/Urgent care.
Flank chest pain (pain under right rib cage) and Dyspnea on exertion; woke pt up at 0300 on 4/9/21 Chest pain with deep breathing., fever, and nausea upon presentation to ED Pt denied recent travel or prolonged immobilization Patient diagnosed with   bilateral pulmonary embolism per CTA
Swelling of right upper arm, redness, soreness, some breaks in skin noted. Mom stated pt was vomiting on 2nd day and had some low grade fever and some diarrhea. Given Benadryl liquid 1 1/2 tsp.
COVID test result positive; COVID test result positive; 22Apr2022 emails with reports of illness; This is a spontaneous report received from a non-contactable reporter(s) (Nurse).  A 46-year-old male patient received BNT162b2 (BNT162B2), on 28Jan2021 as dose 1, single (Lot number: EL3247), on 17Feb2021 as dose 2, single (Lot number: EL3247) and on 22Oct2021 as dose 3 (booster), single (Lot number: FF2589) at the age of 45 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious) with onset 22Apr2022, outcome "unknown", described as "22Apr2022 emails with reports of illness"; COVID-19 (medically significant), VACCINATION FAILURE (medically significant) all with onset 22Apr2022, outcome "unknown" and all described as "COVID test result positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (22Apr2022) Positive, notes: COVID test type post vaccination: Unknown. It was unknown if therapeutic measures were taken as a result of covid-19, illness. Clinical course: Prior to the vaccination, the patient diagnosed with COVID-19 was unknown. Since the vaccination, the patient has been tested positive for COVID-19. It was unknown, whether the patient received any other vaccines prior to the COVID-19 vaccine.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the information provided, known drug safety profile and plausible temporal association, the causality between BNT162B2 and Vaccination failure, Covid 19 cannot be completely excluded
I exp swollen lymph nose on right clavicle. The swelling still there much smaller now
heart went to a-fib; It's like I got a flesh eating something in my hand creeping up to my wrist; retain fluid like when I get a bug bite/ a gooey-like substance on my skin; retain fluid like when I get a bug bite/ bugs are really attacking me this year; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not provided), via an unspecified route of administration on 12Mar2021 at dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not provided), via an unspecified route of administration on 19Feb2021 at dose 1, single for COVID-19 immunization. The patient reported that she had rather get the flu and pneumonia shot because BNT162B2 caused her to retain fluid like when she gets a bug bite. The bugs were really attacking her this year and it caused a gooey-like substance on her skin. The mosquitoes have bothered her before, but not to this extreme. It was like she had a flesh eating something in her hand creeping up to her wrist. She reported that she also went to the hospital overnight from an unspecified date in 2021 to an unspecified date in 2021 because her heart went to A-fib, she had a fast heart rate. The events occurred on Jun2021. She asked if anyone else reported late side effects like hers. Initially, the patient was concerned about getting her flu and pneumonia shot. She asked if she could get the flu shot since she already received both COVID shots. She then reported that there is a possible third dose in Nov2021, but she thought about not getting the booster or to wait until next spring. She added that she had a flu shot and pneumonia shot and wanted to know if getting the vaccine will still be effective on her. The outcome of the events was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Swelling, redness and itching with increased redness and pruritus after application HC17 ointment at 6 days. Slowly resolved. No neurovascular  compromise. Itching still persists.
During an in-store Flu clinic, I inadvertently gave Flublok vaccine to a patient that wasn't age-appropriate. I notified the patient's parents concerning the error. The parents had some questions about the possible side effects of the vaccine.  They said that their child was doing well. There seem to be no negative effects from the vaccine.
Had Pfizer Covid booster shot after Moderna My armpit, side of my limp nodes are swollen and painful
Flu like symptoms; chills; his hair hurt; sick; Received booster shot on 07Dec21 with ongoing leg and large muscle pain/muscle pain was in his legs and arms; booster; Received booster shot on 07Dec21 with ongoing leg and large muscle pain; fatigue; Achy/everything hurt; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from information team. The reporter is the patient.  A 58 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 07Dec2021 10:00 (Lot number: FH8030) at the age of 58 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "muscle relaxer" (unspecified if ongoing). Concomitant medication(s) included: METHOCARBAMOL taken for muscle relaxant therapy. Vaccination history included: Bnt162b2 (Dose of Covid-19 Shot, Lot- EW0171: Exp- Unknown; Administered in left arm), administration date: 23Apr2021, when the patient was 58 years old, for COVID-19 Immunization, reaction(s): "slight fatigue", "muscle soreness"; Bnt162b2 (Second Dose of Covid-19 Shot, Lot- EW0183; Exp- Unknown; Administered in left arm), administration date: 17May2021, when the patient was 58 years old, for COVID-19 Immunization, reaction(s): "slight fatigue", "muscle soreness". The following information was reported: IMMUNISATION (non-serious) with onset 07Dec2021 10:00, outcome "unknown", described as "booster"; PAIN IN EXTREMITY (non-serious) with onset 07Dec2021, outcome "not recovered", described as "Received booster shot on 07Dec21 with ongoing leg and large muscle pain"; MYALGIA (non-serious) with onset 07Dec2021 10:00, outcome "not recovered", described as "Received booster shot on 07Dec21 with ongoing leg and large muscle pain/muscle pain was in his legs and arms"; INFLUENZA LIKE ILLNESS (non-serious) with onset 08Dec2021, outcome "recovering", described as "Flu like symptoms"; PAIN (non-serious) with onset Dec2021, outcome "unknown", described as "Achy/everything hurt"; FATIGUE (non-serious) with onset 07Dec2021, outcome "not recovered", described as "fatigue"; CHILLS (non-serious) with onset 08Dec2021, outcome "unknown", described as "chills"; HAIR INJURY (non-serious) with onset 08Dec2021, outcome "unknown", described as "his hair hurt"; ILLNESS (non-serious) with onset 08Dec2021, outcome "unknown", described as "sick".  No follow-up attempts are possible. No further information is expected.  Follow-up (21Dec2021): This is a spontaneous follow-up report received from a same contactable consumer. This 58 year old female consumer (patient) reporter for her self that: Updated information: Events Added. Historical vaccine details updated. Vaccination facility information updated. Concomitant information updated.
This spontaneous report as received from Licensed Practical Nurse refers to a patient of unknown age and gender. No information regarding current condition, medical history or drug allergies were reported. On 16-SEP-2014, patient was vaccinated with first dose of GARDASIL injection (also reported as confirmed as not GARDASIL 9) (strength, dose unit and route unknown). No concomitant therapy was reported. On 02-DEC-2014 and 03-MAR-2015 the patient was vaccinated with second dose and third dose of GARDASIL (strength, dose unit and route unknown) respectively (inappropriate schedule of drug administration). No adverse symptoms were reported. The outcome of event was unknown. No further information provided. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history was not reported. On 16-MAR-2018, the patient was vaccinated with an improperly stored ROTATEQ lot # N016457, expiration date 16-DEC-2018, oral for prophylaxis. The vaccine underwent a temperature excursion of 32 to 35 degrees Fahrenheit for 28 hours. There was a previous temperature excursion of 47 to 77 degrees Fahrenheit for 3 hours. Digital data logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1803USA008738: US-009507513-1803USA010707.
Stomach hurt, body red and itchy, mouth itchy, throat felt constricted. Reacted within 15 minutes after injection. Treated in ER with epinephrine, Benadryl, Solu-medrol. By 1-yr-old experienced first allergic food reaction to milk and eggs. No reaction that we recall to 1st MMR vaccination but have since waived further MMR shots as well as flu and chicken pox vaccinations due to egg protein.
Patient is a 16-year-old, male with no known medical history. At 2:48 pm, the patient received a dose of the Janssen vaccine, (lot number 1808980, expires on 06/20/2021) on left deltoid, given by RN. RN confirmed the name and date of birth of patient, but reportedly forgot to check the patient's age. Patient left to EMT waiting area while his mother stayed with RN to edit her vaccination card. At 2:49 pm, the patient's mother reportedly stated "I'm so glad he just turned 16 so he can get the vaccine!" RN l immediately notified RN of situation. RN asked the patient how he was feeling at 2:51, to which his response was "fine". Patient presented via hand off from RN to EMT at 2:55 pm. Nurse report stated that patient was 16 years old and given the Janssen vaccine. At 3:00 pm, EMT, began to monitor the patient's vitals, which are as follows: HR 75 BPM, 118 systolic BP, 3 second capillary refill. Patient presented GCS 15, no symptoms of allergic reaction. Skin was pink and dry. Patient was sitting upright and breathing adequately with no difficulty. Patient reports feeling "fine" at 3:00 pm. At 3:05 pm the patient's vitals were: 128 systolic BP. At 3:10 pm the patient's BP was 128/100. At 3:15 pm the patient's  systolic BP was 122. At 3:20 pm the patient's systolic BP was 124. At 3:25 pm the patient's BP was 122/82 with a HR of 58 BPM. Throughout the 30 minute observation period, the patient and his mother were provided with education on the contraindication of Janssen vaccine and children under the age of 16. The patient's mother verbalized understanding of teaching and stated she would follow up with patient's PCP. The patient and his mother left the facility at 3:33 pm. The patient's gait was steady and balanced. The patient was driven home by his mother shortly after leaving the facility.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 07-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). On 07-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided; Sender's Comments: Based on the current available information and the temporal association between the use of ht eproduct and the start date of the event a causal relationship cannot be excluded.
1.5 wk duration of pain and hypertonicity of left cervical muscles with tingling of left side of face down to left elbow. Unrelieved with conservative care and OTC NSAIDs.
After an hour of vaccination numb face and brain while driving. Lasted a few seconds. Almost passed out while driving. Thereafter, vertigo. Which began after 2 weeks of vaccination.
Itches; Still a little red; Arm was swollen; Itchy spot; Large red sore; Arm was red; Sore; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm was red), PAIN (Sore), RASH MACULAR (Large red sore), PRURITUS (Itches) and RASH ERYTHEMATOUS (Still a little red) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Sulfonamide allergy and Drug allergy (Clindamycin).   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced ERYTHEMA (Arm was red) and PAIN (Sore). On 03-Mar-2021, the patient experienced RASH MACULAR (Large red sore) and VACCINATION SITE PRURITUS (Itchy spot). On an unknown date, the patient experienced PRURITUS (Itches), RASH ERYTHEMATOUS (Still a little red) and PERIPHERAL SWELLING (Arm was swollen). The patient was treated with HYDROCORTISONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Arm was red), PAIN (Sore), RASH MACULAR (Large red sore), PRURITUS (Itches), RASH ERYTHEMATOUS (Still a little red), PERIPHERAL SWELLING (Arm was swollen) and VACCINATION SITE PRURITUS (Itchy spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-131181 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: added dosage form, added event. added patient demographic, added historical condition; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-131181:2nd dose
Patient received his vaccine and was fine while his sibling received hers. Walked out of the room a few minutes later, then fainted. Came to quickly and was fine.
Pt. falsified vaccine history and DOB stating he had never received a previous COVID vaccine. Due to incorrect DOB given, not able to find pt. in system. After dose given, attempted to enter pt. into system and discovered pt. under different DOB. Pt. had received first dose of Moderna vaccine on 1/5/22 at a different location. Staff called pt., who admitted he was untruthful so he could get the J&J vaccine today. Pt. states he has a job opportunity that requires him to be fully vaccinated, he was unaware when he received the Moderna yesterday that he had to wait 28 days to receive the second dose. Pt. stated he lied because he will lose the job if he waits that long. Nurse instructed pt. to contact PCP with any adverse reactions.
Information has been received on 10-JAN-2017 from a physician regarding a 61 year old male patient with diabetes mellitus. The patient's concurrent conditions, medical history and concomitant therapy were not provided. On 30-DEC-2004, the patient was vaccinated with RECOMBIVAX HB (lot number and expiration not reported), unknown route for prophylaxis. On 05-JAN-2017, the patient had titers drawn for his job and the hepatitis B titer came back as negative for surface antibody. On 10-JAN-2017 the patient was seen in the physician's office and was inadvertently administered a dialysis dose of RECOMBIVAX HB (lot number and expiration not reported) instead of the regular adult dose. The outcome of hepatitis b surface antibody negative and incorrect dose administered was reported as recovered/resolved. No further information was reported. Additional information has been requested.
Unilateral axillary lymphadenopathy on left side. Area tender on palpation. No redness or other discoloration. Lasted approximately 2-3 days.
Patients arm at injection site puffed up instantly.  It looked like a golf ball under the skin.  No other reaction reported or noticed. We had the patient wait around to monitor for any additional symptoms.  Patient called back the next day to report the swelling had completely gone away.
Immediately following administration of vaccine pt reported feeling lightheaded and said they felt like they were going to pass out. Pt. was given a drink of water and a chance to rest. Pt never lost consciousness. Pt. reported severe headache afterwards and metallic taste in mouth that subsided minutes after. Followed up with pt and headache was getting better, but pt. reported neck pain as well that was getting better but had not subsided.
Pt reports she developed erythema at site of the varicella vaccine injection (RUE), N/V/D and fever on 3-3-18 (1 day after MMR II and Varicella vaccines and Tubersol were administered) and her symptoms resolved on 3-7-18. Pt is asymptomatic. For the record, pt never contacted Clinic to inform us of her symptoms nor she presented to another clinic, urgent care or emergency center to seek for care.
Vaccine administered at 4:23p. Onset of non-raised erythema to bilat hands with associated pruritis at 4:33p. VSS: HR 86 BPM, RR 20, Sat 97% RA. Pt denied any other sx at this time. Reports hx of similar sx in past when exposed to known allergen (peanuts, carries Epi-Pen). Reports active hx of asthma for which she carries an inhaler and is prescribed Prednisone to take PRN. Pruritis became more diffuse at 4:33- pt itching her face. No airway involvement. VS remain WNL. No swelling of lips/tongue/throat, no lightheadedness/nausea/abd pain. No noted rash or hives.  Cont. pruritis with pt itching face, scalp, legs, and arms. Benadryl 50 mg PO administered at 4:39pm.  No progression of sx, VSS, O2 sat 98% on RA.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 01-Aug-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Nov-2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Date of Conception was reported as 08-NOV-2020 . Concomitant medications was not reported . Treatment history was not  reported .  Company Comment: This is a case of product exposure during pregnancy with no associated AEs for this 34-year-old female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 34-year-old female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Hypoxic failure secondary to acute on chronic diastolic heart failure; Shortness of breath; Weak; Tired; A spontaneous report was received from a healthcare professional concerning a 90-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced hypoxic failure secondary to acute on chronic diastolic heart failure, shortness of breath, tired, and weak.  The patient's medical history, as provided by the reporter, included chronic diastolic heart failure. Concomitant product use was not provided.  On 15 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 012L20A), intramuscularly for prophylaxis of COVD-19 infection.  On 16 Jan 2021, the patient had shortness of breath, was tired and weak. He was taken to the hospital and diagnosed with hypoxic failure secondary to acute on chronic diastolic heart failure. Treatment for the events included intravenous (IV) bumetanide. The patient was discharged home with oxygen on an unknown date.   Action taken with mRNA-1273 in response to the events was not provided.  The outcome for the events, hypoxic failure secondary to acute on chronic diastolic heart failure, shortness of breath, tired, and weak, was unknown.; Reporter's Comments: Based on  the diagnosis of hypoxic failure secondary to acute on chronic diastolic heart failure provided by the hospital, the event is assessed as unlikely related to mRNA-1273. Further information has been requested.
pt recv vax & in early 1996 several months p/vax pt devel severe abd pain & a blood clot which affected renal arteries & was hosp
This is a spontaneous report from a contactable physician via a sales representative. This physician reported that a 4-year-old child (unknown gender) received full 4 dose series of PREVNAR13. Medical history and concomitant medications were unknown. On an unknown date, titers are checked and they were found low or inadequate.
Pfizer on 3/15 and 4/5. Positive on 10/4
Patient reported he was going to "blackout." He was conscious and able to answer all questions correctly. Patient moved to medical; then to the infirmary for further care. In the infirmary, under the care of a doctor, patient received 1.5L of NS, and low-flow O2 nasal cannula at 2L/min. Patient was bradycardic and hypotensive initially. After the treatment, (about 3 hours), patient felt much better and vitals were with in normal limits. Patient never reported any typical allergic reactions, such as airway swelling or difficulty breathing.
Tonic Clonic seizure The patient (my daughter) does have epilepsy, but seizures are mostly well controlled with medication.  She had not missed any medication doses. She had the  first dose of the Pfizer Covid vaccine at 3:50 pm on 4/27/2021. She had a seizure later that night at around 10 pm.
pt came to hosp 8DEC94 c/o sweating, shoulder pain & dizziness p/vax on 7DEC94; pt 4th & 5th fingers numb & severe pain & swelling of lt arm; c/o t103 & chills; pt appears septic & t101.7; lt arm cellulitis; WBC 27.6; sed 31; tx ATB, APAP
Has cluster (#7) of seizures morning after flu shot. One seizure lasted 3 minutes. Has epilepsy, but has never had this many seizures.
Woke up itching and noticed hives, bumps and bruising and was given Benadryl.
Moderna vaccine was given to a 17 yo male. This vaccine is not currently authorized to be given to patients under 18 yoa.